Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Current Assets (2020 - 2026)

Journey Medical filings provide 6 years of Current Assets readings, the most recent being $66.9 million for Q4 2025.

  • On a quarterly basis, Current Assets rose 38.8% to $66.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $66.9 million, a 38.8% increase, with the full-year FY2025 number at $66.9 million, up 38.8% from a year prior.
  • Current Assets hit $66.9 million in Q4 2025 for Journey Medical, up from $56.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $90.3 million in Q1 2022 to a low of $44.7 million in Q3 2023.
  • Median Current Assets over the past 5 years was $56.4 million (2023), compared with a mean of $61.6 million.
  • Biggest five-year swings in Current Assets: soared 139.75% in 2021 and later crashed 43.86% in 2023.
  • Journey Medical's Current Assets stood at $84.5 million in 2021, then dropped by 8.06% to $77.7 million in 2022, then dropped by 27.32% to $56.5 million in 2023, then decreased by 14.66% to $48.2 million in 2024, then surged by 38.8% to $66.9 million in 2025.
  • The last three reported values for Current Assets were $66.9 million (Q4 2025), $56.4 million (Q3 2025), and $51.3 million (Q2 2025) per Business Quant data.